This FFJ Portfolio - July 2022 Report discloses my investment activity. Purchases During the month, we had a window of opportunity to acquire reasonably valued shares. Altogether I deployed ~$52,500 USD and ~$943 CDN by adding to several positions. July 4 - In conjunction with my Goldman Sachs’ Earnings Are Becoming More Resilient and Diversified [...]
On July 27, 2022, Automatic Data Processing (ADP) released strong Q4 and FY2022 results and an encouraging FY2023 outlook. Despite an increase in ADP's adjusted diluted EPS guidance relative to FY2022 results, the sudden surge in ADP's share price has led to a slight deterioration in its valuation from the time of my last analysis. [...]
In my recent CME Group – The Risk Of Relying On Stock Screeners post, I disclose that all the stock screeners I have reviewed reflect incorrect dividend metrics when a company has a special variable dividend policy. Rollins, Inc. (ROL), like CME, has a special variable dividend policy. I last reviewed ROL in my April [...]
Some investors rely exclusively on stock screeners to make investment decisions. CME Group, with its unique dividend policy, is a good example of the risk of relying on stock screeners to make investment decisions. Looking at several different stock screeners in preparation for this post, I see not one that accurately reflects CME's dividend yield! [...]
Raytheon Technologies (RTX), a defense and commercial aerospace powerhouse, is benefitting from an increasingly hostile global political climate. I last reviewed RTX in my January 26, 2022 post at which time it had just released its Q4 and FY2021 results and FY2022 outlook. RTX has now released Q2 and YTD2022 results and its FY2022 outlook [...]
Investors should invest in great companies, such as Moody's Corporation (MCO), when they temporarily fall out of favour. I have been increasing my exposure to wide moat MCO on weakness. I last reviewed MCO in my May 4, 2022 Moody's Current Headwinds Present a Buying Opportunity post. At the time, it had just reported Q1 [...]
I last reviewed Intuitive Surgical (ISRG) in my April 23, 2022 post at which time it had just released Q1 2022 results. Following the July 21 market close, ISRG released Q2 results. It continues to experience headwinds from: COVID-driven lockdowns in China, ISRG's 2nd largest market; supply chain disruptions with semiconductor component delays impacting the [...]
Portfolio Insight asked authors of leading investing websites to share the 10 best dividend stocks now. I recommend Blackstone Inc. (BX) and Brookfield Asset Management (BAM-a.TO and BAM). The remaining 8 companies are recommendations by other guest contributors. My reasons for liking these two asset managers are found in the following posts: Blackstone Should Richly [...]
Based on my analysis, Blackstone Inc. (BX) should richly reward long-term shareholders. Investors should consider the current share price weakness as a window of opportunity. I last reviewed BX in my April 25, 2022 Consider Blackstone For Alternative Asset Exposure guest post at Dividend Power; prior BX posts are accessible in the Archives section of [...]
Wealth creation through Danaher (DHR) share ownership is possible. Share price weakness despite strong results and a somewhat more favourable valuation relative to the last several months of 2021, provides investors with a window of opportunity. I last wrote about Danaher (DHR) in my April 21, 2022 post following the release of Q1 2022 results. [...]